key: cord-0039484-orr52uc2
authors: Chugh, Tulsi
title: Middle East respiratory syndrome
date: 2017-06-27
journal: nan
DOI: 10.1016/j.cmrp.2017.06.002
sha: 7ffba1991ada8eb9ee1c20b53f9d98b4a00dbe42
doc_id: 39484
cord_uid: orr52uc2

nan

Middle East respiratory syndrome The Middle East Respiratory Syndrome is caused by an emerging zoonotic Coronavirus (MERS CoV). The disease, as of September 2016, is known to have occurred in 1800 cases with 643 deaths worldwide. 1 The camels (dromedaries with single hump) are the principal reservoir but South American camelids (Llamas), alpacas and pigs also get infected as evidenced by various serological and experimental animal studies.

However, human-human transmission is responsible for most of the clinical cases. The causative agents MERS-CoV binds to a receptor binding site dipeptidyl peptidase-4 (DPP4) which is distributed in the respiratory passages of susceptible animals and humans. Horses have a high expression and wide distribution of the virus receptor DPP4 but do not get infected due to innate immunity. Epidemiologic studies show an evidence of endemic MERS-CoV infection in Africa and Saudi Arabia since as far back as 1983 and 1992 respectively. There is no known antiviral agent or vaccine as yet for the treatment or control of the spread. An outbreak of the disease was reported in South Korea (May 2015-July 2015) with a total of 186 infected cases with 36 deaths and a high political and economic fallout. 2 The role of hospital infection control policies in containment of the spread of disease is critical. The author of the article in this issue (Kumar A) 3 has discussed this very ably from his personal experience in one of the hospitals in Saudi Arabia.

WHO has warned India (2016) of the possibility of this disease because of the Indians working in the Middle East countries and travel of infected persons back home and animal trade. Furthermore, Pakistan has a very high population of dromedary camels, exceeding 1 million. A study of sera of 565 animals in Pakistan during 2012-15 showed ELISA positivity (55.8%) and 39.5% were confirmed by microneutralisation (MN). The rate of MN positivity ranged in different districts of Punjab, Pakistan; being highest in Rahim Yar Khan (82.9%) which shares a border with Rajasthan, India. 4 There is thus a risk of human exposure in India both from Middle East countries and shared border with Pakistan.

There are no known cases reported in India as yet. However, there is a need to be vigilant and make early diagnosis in all suspected cases. There is also a need for veterinarians to identify the disease in animals since infected animals have just runny nose the only symptom.

It was first isolated in a patient in Saudi Arabia, who died of severe acute respiratory infection in Jeddah in June 2012. A South Korean got infected on a trip to several Arabian Middle East countries in 2015 which led to an outbreak in his home country after his return. FDA, CDC and WHO have recommended serology using paired sera and confirmatory test of Real Time Reverse Transcriptase PCR assay in respiratory secretions [Tracheal aspirate, bronchoial lavage, blood, and stool. India has strategic partnership with heavy passenger traffic, pilgrimage, employment tourism, and business and thus a high risk in our country. Are we ready with robust healthcare for management, infection and control with public health surveillance, isolation and quarantine facilities? [5] [6] [7] 

The author has nothing to disclose.

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Update

Livestock susceptibility to infection with middle east respiratory syndrome Coronavirus

Middle east respiratory syndrome Coronavirus outbreak: Saudi Arabian experience

Serologic evidence for MERS-CoV infection in dromedary camels

MERS may not be SARS; but India is still vulnerable

MERS outbreak: is India prepared?

Combating the spread of middle east respiratory syndrome Coronavirus: India perspective

Ansari Nagar, Mahatma Gandhi Marg, Delhi, IndiaE-mail address: chughtd@gmail